|
Inspire
Reports First Quarter 2008 Financial Results
- Q1 2008 Revenue Increased by 35% over Q1 2007
 Webcast
Replay Conference Call
800-642-1687 (US)
706-645-9291(International)
ID number is 44700402
(available until May 22,
2008)
Inspire
Announces Poster Presentations at 2008 Association for Research
in Vision and Ophthalmology Annual Meeting
Inspire
Announces Webcasts of Presentations at Morgan Stanley and Deutsche
Bank Healthcare Conferences
Morgan
Stanley Webcast
May 1, 2008 11:20am
ET
Deutsche
Bank Webcast
May
6, 2008 11:30am ET
Inspire
to Discontinue Development of Epinastine Nasal Spray
Inspire
Announces Poster Presentation at American Society of Cataract and
Refractive Surgery Annual Symposium
Inspire
Announces Poster Presentations at 2008 American Academy of Allergy,
Asthma & Immunology (AAAAI) Annual Meeting
Inspire
Announces Webcast of Presentation at Cowen and Company Health Care
Conference
Inspire
Director William R. Ringo to Resign Board Position
Inspire
Announces Webcast of Presentation at Susquehanna Healthcare Conference
Inspire
Reports Fourth Quarter and Full Year 2007 Financial Results
Inspire
Initiates Second Phase 3 Cystic Fibrosis Trial
Inspire
Announces Webcasts of Presentations at BIO CEO and Roth Growth Stock
Conferences
Inspire
Provides 2008 Financial Guidance
Inspire
Announces Its Termination of Bilastine Licensing Agreement
Inspire
Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
Page
last updated: 08-May-2008
|
